Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, United States.
Front Immunol. 2023 Mar 14;14:1130172. doi: 10.3389/fimmu.2023.1130172. eCollection 2023.
Genomic instability is a key driving force for the development and progression of many neurodegenerative diseases and central nervous system (CNS) cancers. The initiation of DNA damage responses is a critical step in maintaining genomic integrity and preventing such diseases. However, the absence of these responses or their inability to repair genomic or mitochondrial DNA damage resulting from insults, including ionizing radiation or oxidative stress, can lead to an accumulation of self-DNA in the cytoplasm. Resident CNS cells, such as astrocytes and microglia, are known to produce critical immune mediators following CNS infection due to the recognition of pathogen and damage-associated molecular patterns by specialized pattern recognition receptors (PRRs). Recently, multiple intracellular PRRs, including cyclic GMP-AMP synthase, interferon gamma-inducible 16, absent in melanoma 2, and Z-DNA binding protein, have been identified as cytosolic DNA sensors and to play critical roles in glial immune responses to infectious agents. Intriguingly, these nucleic acid sensors have recently been shown to recognize endogenous DNA and trigger immune responses in peripheral cell types. In the present review, we discuss the available evidence that cytosolic DNA sensors are expressed by resident CNS cells and can mediate their responses to the presence of self-DNA. Furthermore, we discuss the potential for glial DNA sensor-mediated responses to provide protection against tumorigenesis versus the initiation of potentially detrimental neuroinflammation that could initiate or foster the development of neurodegenerative disorders. Determining the mechanisms that underlie the detection of cytosolic DNA by glia and the relative role of each pathway in the context of specific CNS disorders and their stages may prove pivotal in our understanding of the pathogenesis of such conditions and might be leveraged to develop new treatment modalities.
基因组不稳定性是许多神经退行性疾病和中枢神经系统 (CNS) 癌症发展和进展的关键驱动力。启动 DNA 损伤反应是维持基因组完整性和预防此类疾病的关键步骤。然而,这些反应的缺失或无法修复因刺激(包括电离辐射或氧化应激)而导致的基因组或线粒体 DNA 损伤,会导致细胞质中自我 DNA 的积累。众所周知,中枢神经系统感染后,驻留的中枢神经系统细胞(如星形胶质细胞和小胶质细胞)会产生关键的免疫介质,这是由于专门的模式识别受体 (PRR) 识别病原体和损伤相关分子模式。最近,多种细胞内 PRR,包括环鸟苷酸-腺苷酸合酶、干扰素 γ 诱导蛋白 16、黑色素瘤缺失 2 和 Z 型 DNA 结合蛋白,已被鉴定为细胞质 DNA 传感器,并在胶质细胞对感染因子的免疫反应中发挥关键作用。有趣的是,这些核酸传感器最近被证明可以识别内源性 DNA 并在周围细胞类型中引发免疫反应。在本综述中,我们讨论了现有证据表明,细胞质 DNA 传感器由驻留的中枢神经系统细胞表达,并可以介导它们对自身 DNA 的反应。此外,我们讨论了胶质细胞 DNA 传感器介导的反应的潜力,以提供针对肿瘤发生的保护与潜在有害神经炎症的启动,后者可能引发或促进神经退行性疾病的发展。确定胶质细胞检测细胞质 DNA 的机制以及每种途径在特定中枢神经系统疾病及其阶段中的相对作用,可能对我们理解这些疾病的发病机制至关重要,并可能被利用来开发新的治疗方法。